Efficacy of cytisine in helping smokers quit: systematic review and meta-analysis.

Thorax

Volumn 68, Issue 11, 2013, Pages 1037-1042

  Hajek, Peter ^a   McRobbie, Hayden ^b   Myers, Katie ^b  

^a QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALKALOID; AZOCINE DERIVATIVE; CYTISINE; NICOTINE; QUINOLIZINE DERIVATIVE;

ANTAGONISTS AND INHIBITORS; HUMAN; META ANALYSIS; PROCEDURES; PUBLIC HEALTH; SMOKING; SMOKING CESSATION; TREATMENT OUTCOME;

ALKALOIDS; AZOCINES; HUMANS; NICOTINE; PUBLIC HEALTH; QUINOLIZINES; SMOKING; SMOKING CESSATION; TREATMENT OUTCOME;

EID: 84891552782     PISSN: None     EISSN: 14683296     Source Type: Journal    
DOI: 10.1136/thoraxjnl-2012-203035     Document Type: Review

References (36)

1. Tutka P, Zatonski W. Cytisine for the treatment of nicotine addiction: from a molecule to therapeutic efficacy. Pharmacol Rep 2006;58:777-98.
2. Coe JW, Vetelino MG, Bashore CG, et al. In pursuit of alpha4beta2 nicotinic receptor partial agonists for smoking cessation: carbon analogs of (-)-cytisine. Bioorg Med Chem Lett 2005;15:2974-9.
3. Kolotkin RL, Crosby RD. Psychometric evaluation of the impact of weight on quality of life-lite questionnaire (IWQOL-lite) in a community sample. Qual Life Res 2002;11:157-71.
4. McRobbie H, Hajek P, Bullen C, et al. Rapid review of non-NHS treatments for smoking cessation. London: National Institute of Health and Clinical Excellence, 2006.
5. Etter J-F. Cytisine for smoking cessation: a literature review and a meta-analysis. Arch Intern Med 2006;166:1553-9.
6. West R, Hajek P, Stead L, et al. Outcome criteria in smoking cessation trials: proposal for a common standard. Addiction 2005;100:299-303.
7. Vinnikov D, Brimkulov N, Burjubaeva A. A double-blind, randomised, placebo-controlled trial of cytisine for smoking cessation in medium-dependent workers. J Smoking Cessation 2008;3:57-62.
8. West R, Zatonski W, Cedzynska M, et al. Placebo-controlled trial of cytisine for smoking cessation. N Engl J Med 2011;365:1193-200.
9. National Institute for Health and Clinical Excellence (NICE). Methods for the development of NICE public health guidance. 2nd edn. London: NICE, 2009.
10. Review Manager (RevMan) (program). Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2008.
11. Higgins J, Green S. Cochrane Handbook for Systematic Reviews of Interventions. Version 5.0.2 (updated September 2009). The Cochrane Collaboration, 2008.
12. Bacvarov VI. Medicinal breaking of the smoking habit. (Remarks to G. Scharfenberg, E. Winkelvosss and S. Benndorf. Munchen Med Wochr 1967;109:1687-9.) Munchen Med Wochr 1967;109:2663-5.
13. Paun D, Franze J. Tabex-registering and treatment of smokers with chronic bronchitis in the consultation against tobacco-smoking - Berlin. Medico-biologic Info 1970;3:15-9
14. Stoyanov S, Yanachkova M. On the therapeutic effectiveness and tolerance of Tabex. Savremenna Med 1972;23:2088-91.
15. Maliszewski L, Straczynski A. Therapeutic use of Tabex. Wiad Lek 1972;25:2207-10.
16. Zatonski W, Cedzynska M, Tutka P, et al. An uncontrolled trial of cytisine (Tabex) for smoking cessation. Tob Control 2006;15:481-4.
17. Paun D, Franze J. Breaking the smoking habit using cytisin containing "Tabex" tablets. Dtsch Gesundheitsw 1968;23:2088-91.
18. Scharfenberg G, Benndorf S, Kempe G. Cytisine (Tabex) as a pharmaceutical aid in stopping smoking. Dtsch Gesundheitsw 1971;26:463-5.
19. Benndorf S, Kempe G, Scharfenberg G, et al. (Results of smoking cessation treatment with cytisin (Tabex)) (German). Dtsch Gesundheitsw 1968;23:2092-6.
20. Benndorf S, Scharfenberg G, Kempe G, et al. Smoking withdrawal treatment with cytisin (Tabex). Results of a semi-annual survey of former smokers after 4 weeks of therapy. Dtsch Gesundheitsw 1970;24:774-6.
21. Schmidt F. Medikamentose Unterstutzung der Raucherentwohnung: Bericht uber Versuche an uber 500 Rauchern im Doppelblindversuch. MMW Munch Med Wochenschr 1974;116:557-64.
22. Marakulin VS, Komarov VM, Chuprin VV. Treatment of nicotinism. Voen Med Zh 1984:55-8.
23. Dobreva D, Danchev N. Tabex - Sopharma - natural alternative for smoking cessation and treatment of nicotine dependence. Pharmacia 2005;52:30-5.
24. Ostrovskaia TP. Results of clinical investigation of anti-nicotine drug patches (in Russian). Med Tekh 1994;(3):42-3.
25. Scharfenberg G, Benndorf S, Kempe G. Cytisine (Tabex) as a pharmaceutical aid in stopping smoking. Dtsch Gesundheitsw 1971;26:463-5.
26. Stead LF, Perera R, Bullen C, et al. Nicotine replacement therapy for smoking cessation. Cochrane Database Syst Rev 2008;(1):CD000146.
27. Hughes JR, Stead LF, Lancaster T. Antidepressants for smoking cessation. Cochrane Database Syst Rev 2007;(1):CD000031.
28. Cahill K, Stead LF, Lancaster T. Nicotine receptor partial agonists for smoking cessation. Cochrane Database Syst Rev 2012;(4).
29. Jorenby DE, Hays JT, Rigotti NA, et al. Efficacy of varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, vs placebo or sustained-release bupropion for smoking cessation: a randomized controlled trial. JAMA 2006;296:56-63.
30. US Department of Health and Human Services (USDHHS). Treating tobacco use and dependence: 2008 update. Rockville, MD: USDHHS, Agency for Healthcare Research Quality, 2008.
31. Shiffman S, Rolf CN, Hellebusch SJ, et al. Real-world efficacy of prescription and over-the-counter nicotine replacement therapy. Addiction 2002;97:505-16.
32. Godlee F. Clinical trial data for all drugs in current use. BMJ 2012;345:e7304.
33. Richards HG, Stephens A. A fatal case of laburnum seed poisoning. Med Sci Law 1970;10:260-6.
34. Hughes JR, Keely J, Naud S. Shape of the relapse curve and long-term abstinence among untreated smokers. Addiction 2004;99:29-38.
35. Hajek P, McRobbie HJ, Myers KE, et al. Use of varenicline for 4 weeks before quitting smoking: decrease in ad lib smoking and increase in smoking cessation rates. Arch Intern Med 2011;171:770-7.
36. Pisinger C, Jorgensen MM, Moller NE, et al. A cluster randomized trial in general practice with referral to a group-based or an Internet-based smoking cessation programme. J Public Health (Oxf) 2010;32:62-70.